Biocon Chief Hints In Tweet Firm Would Quit India Over Regulatory Delays
This article was originally published in PharmAsia News
Executive Summary
Biocon's chairman appeared to indicate in a brief message that she would consider relocating her company out of India if the government cannot improve its regulations that affect innovation in the drug industry.